Indegene (BSE:544172) - Stock Price, News & Analysis

544172 Stock Overview

Operates as a life sciences commercialization company in India, the United States, Europe, and internationally. More details

544172 fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	3/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (41.1x) is below the Life Sciences industry average (49.1x)

Earnings are forecast to grow 18.44% per year

Earnings grew by 38.3% over the past year

Risk Analysis

Significant insider selling over the past 3 months

Indegene Limited Competitors

Akums Drugs and Pharmaceuticals

NSEI:AKUMS

₹100.7b

Syngene International

NSEI:SYNGENE

₹348.8b

Innova Captab

NSEI:INNOVACAP

₹58.1b

Tarsons Products

NSEI:TARSONS

₹20.6b

Price History & Performance

Summary of all time highs, changes and price drops for Indegene
Historical stock prices
Current Share Price	₹639.35
52 Week High	₹736.60
52 Week Low	₹468.90
Beta	0
11 Month Change	-5.16%
3 Month Change	13.48%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.04%

Recent updates

Shareholder Returns

	544172	IN Life Sciences	IN Market
7D	-3.1%	3.2%	0.5%
1Y	n/a	48.3%	27.5%

Return vs Industry: Insufficient data to determine how 544172 performed against the Indian Life Sciences industry.

Return vs Market: Insufficient data to determine how 544172 performed against the Indian Market.

Price Volatility

Is 544172's price volatile compared to industry and market?
544172 volatility
544172 Average Weekly Movement	6.5%
Life Sciences Industry Average Movement	6.3%
Market Average Movement	6.1%
10% most volatile stocks in IN Market	9.1%
10% least volatile stocks in IN Market	4.0%

Stable Share Price: 544172 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 544172's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1998	4,367	Manish Gupta	www.indegene.com

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies.

Indegene Limited Fundamentals Summary

How do Indegene's earnings and revenue compare to its market cap?
544172 fundamental statistics
Market cap	₹153.20b
Earnings (TTM)	₹3.73b
Revenue (TTM)	₹27.10b

41.1x

P/E Ratio

5.7x

P/S Ratio

Is 544172 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544172 income statement (TTM)
Revenue	₹27.10b
Cost of Revenue	₹588.00m
Gross Profit	₹26.51b
Other Expenses	₹22.78b
Earnings	₹3.73b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	15.59
Gross Margin	97.83%
Net Profit Margin	13.77%
Debt/Equity Ratio	0%

How did 544172 perform over the long term?

See historical performance and comparison

Indegene BSE:544172 Stock Report